Medical chip expert Sencure, with offices in Roden and Enschede, has completed a 5-million-euro investment round. The funding will primarily be used to expedite the industrialization of the company’s flagship product, the SNCE-800 chip, which can measure high-quality electrophysiological signals with extreme power efficiency. Led by Cottonwood Technology Fund, the round included participation from the Northern Netherlands Investment Agency (NOM) and current investor Lumana Invest.
The SNCE-800 enables medical wearable biosensors to capture high-quality signals like ECG and EEG while operating on minimal power consumption. This provides healthcare professionals with invaluable insights into physiological conditions without sacrificing comfort or battery life. Target applications include remote monitoring and diagnostics for cardiac, neurological and respiratory cases.